QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 3, 2003, 23(22):7967-7973

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (26) Citing Articles via Google Scholar Google Scholar Articles by Garnier, P. Articles by Swanson, R. A. Search for Related Content PubMed PubMed Citation Articles by Garnier, P. Articles by Swanson, R. A.

 Previous Article  |  Next Article 

Ischemic Preconditioning by Caspase Cleavage of Poly(ADP-Ribose) Polymerase-1

Philippe Garnier, Weihai Ying, and Raymond A. Swanson

Department of Neurology, University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121

A transient, sublethal ischemic interval confers resistance to a subsequent, otherwise lethal ischemic insult, in a process termed ischemic preconditioning. Poly(ADP-ribose) polymerase-1 (PARP-1) normally functions in DNA repair, but extensive PARP-1 activation is a major cause of ischemic cell death. Because PARP-1 can be cleaved and inactivated by caspases, we investigated the possibility that caspase cleavage of PARP-1 could contribute to ischemic preconditioning. Murine cortical cultures were treated with glucose deprivation combined with 0.5 mM 2-deoxyglucose and 5 mM azide ("chemical ischemia") to model the reversible energy failure that occurs during transient ischemia in vivo. Cortical cultures preconditioned with 15 min of chemical ischemia showed increased resistance to subsequent, longer periods of chemical ischemia. These cultures were also more resistant to the PARP-1 activating agent, N-methyl-N'-nitro-N-nitrosoguanidine, suggesting reduced capacity for PARP-1 activation after preconditioning. Immunostaining for the 89 kDa PARP-1 cleavage fragment and for poly(ADP-ribose) formation confirmed that PARP-1 was cleaved and PARP-1 activity was attenuated in the preconditioned neurons. Preconditioning also produced an increase in activated caspase-3 peptide and an increase in caspase-3 activity in the cortical cultures. A cause-effect relationship between caspase activation, PARP-1 cleavage, and ischemic preconditioning was supported by studies using the caspase inhibitor Ac-Asp-Glu-Val-Asp-aldehyde (DEVD-CHO). Cultures treated with DEVD-CHO after preconditioning showed reduced PARP-1 cleavage and reduced resistance to subsequent ischemia. These findings suggest a novel interaction between the caspase- and PARP-1-mediated cell death pathways in which sublethal caspase activation leads to PARP-1 cleavage, thereby increasing resistance to subsequent ischemic stress.

Key words: apoptosis; brain; culture; cycloheximide; mouse; tolerance

---

Received Feb 4, 2003; revised June 24, 2003; accepted July 10, 2003.

This article has been cited by other articles:

				H. Wang, M. Zhou, J. Brand, and L. Huang Inflammation Activates the Interferon Signaling Pathways in Taste Bud Cells J. Neurosci., October 3, 2007; 27(40): 10703 - 10713. [Abstract] [Full Text] [PDF]

				H. Tanaka, H. Yokota, T. Jover, I. Cappuccio, A. Calderone, M. Simionescu, M. V. L. Bennett, and R. S. Zukin Ischemic Preconditioning: Neuronal Survival in the Face of Caspase-3 Activation J. Neurosci., March 17, 2004; 24(11): 2750 - 2759. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help